WHO's approval for Covaxin likely this month
- Country:
- India
The World Health Organization’s approval for the indigenous COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come this month, official sources said Monday.
The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China's Sinopharm and Oxford-AstraZeneca for emergency use.
Covaxin is one of the six vaccines that have received emergency use authorisation from India's drug regulator and is being used in the nationwide inoculation programme, alongwith Covishield and Sputnik V.
''The WHO approval for Covaxin is likely this month,'' an official source said.
The Centre had told Rajya Sabha in July that all documents required for the WHO’s Emergency Use Listing (EUL) have been submitted by Bharat Biotech as of July 9, and the global health body had commenced the review process.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
India US partnership reaches unprecedented levels: Sullivan.
India, Luxembourg hold second round of foreign office consultations in Delhi
India's nominee Jagjit Pavadia re-elected to International Narcotics Control Board
India, Luxembourg hold second round of foreign office consulations in Delhi
India, Kazakhstan assess security challenges, exchange views on cross-border terrorism in South Asia